medroxyprogesterone acetate and Elevated Cholesterol
medroxyprogesterone acetate has been researched along with Elevated Cholesterol in 11 studies
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berenson, AB; Rahman, M; Wilkinson, G | 1 |
| Chayama, K; Higashi, Y; Kimura, M; Kodama, I; Nakagawa, K; Ohama, K; Sanada, M; Tsuda, M | 1 |
| Kremastinos, DT; Kyriakides, ZS; Sbarouni, E | 1 |
| Latrilha, MC; Maranhão, RC; Melo, NR; Pompei, LM; Santos, RD | 1 |
| Koval, JJ; Nisker, JA; Wolfe, BM | 1 |
| Birkenhäger, JC; Deckers, JW; Hoogerbrugge, N; Jansen, H; Meeter, K; Zillikens, MC | 1 |
| Kyriakides, ZS; Sbarouni, E | 1 |
| Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E | 1 |
| Kodama, I; Nakagawa, H; Ohama, K; Sakashita, T; Sanada, M; Tsuda, M | 1 |
| Akerblom, M; Li, C; Samsioe, G | 1 |
| Darling, GM; Davis, SR; Johns, JA; McCloud, PI | 1 |
Trials
7 trial(s) available for medroxyprogesterone acetate and Elevated Cholesterol
| Article | Year |
|---|---|
Effect of simvastatin on serum C-reactive protein during hormone replacement therapy.
Topics: Aged; C-Reactive Protein; Coronary Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Medroxyprogesterone Acetate; Postmenopause; Simvastatin; Time Factors | 2004 |
Effects in post-menopausal women of transdermal estrogen associated with progestin upon the removal from the plasma of a microemulsion that resembles low-density lipoprotein (LDL).
Topics: Administration, Cutaneous; Administration, Oral; Cholesterol Esters; Cholesterol, LDL; Emulsions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Treatment Outcome | 2005 |
Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Norgestrel; Postmenopause; Prospective Studies; Triglycerides | 1998 |
The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
Topics: Aged; Anticholesteremic Agents; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Simvastatin; Treatment Outcome | 1998 |
Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease.
Topics: Aged; Anticholesteremic Agents; Cell Adhesion Molecules; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Male; Medroxyprogesterone Acetate; Middle Aged; Simvastatin | 2000 |
Electrocardiogram pattern in hypercholesterolemic women: the influence of hormone replacement therapy.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Premenopause | 1998 |
Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Humans; Hypercholesterolemia; Lipoprotein(a); Medroxyprogesterone Acetate; Postmenopause; Simvastatin; Treatment Outcome; Triglycerides | 1999 |
Other Studies
4 other study(ies) available for medroxyprogesterone acetate and Elevated Cholesterol
| Article | Year |
|---|---|
Effect of injectable and oral contraceptives on serum lipids.
Topics: Adolescent; Adult; Black or African American; Cholesterol; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Hypercholesterolemia; Hypertriglyceridemia; Longitudinal Studies; Medroxyprogesterone Acetate; Triglycerides; White People; Young Adult | 2009 |
Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Topics: Arteries; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Hypercholesterolemia; Hyperemia; Lipids; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Nitroglycerin; Peptidyl-Dipeptidase A; Plethysmography; Postmenopause; Vascular Resistance | 2002 |
Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease.
Topics: Autoantibodies; Cholesterol, HDL; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Lipoprotein Lipase; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Particle Size; Postmenopause; Smoking | 1998 |
Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy.
Topics: Adult; Aged; Apolipoproteins E; Asian People; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Japan; Medroxyprogesterone Acetate; Middle Aged; Phenotype; Postmenopause; Prospective Studies | 2001 |